Cellectis (CLLS) Short term Debt (2015 - 2026)
Cellectis (CLLS) recorded quarterly Short term Debt of $8.9 million in Q1 2026, down 14.88% quarter-over-quarter from $10.5 million in Q4 2025, and down 46.96% on a YoY basis from $16.8 million in Q1 2025.
Cellectis (CLLS) Short term Debt (2015 - 2026) Analysis & Trends
Cellectis' Short term Debt history runs 11 years deep, the most recent figure standing at $8.9 million for Q1 2026.
- In Q1 2026, Short term Debt fell 46.96% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (down 46.96% YoY), while the FY2025 annual figure was $10.5 million, down 35.17% from the prior year.
- Short term Debt was $8.9 million for Q1 2026 at Cellectis, down from $10.5 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $18.2 million in Q3 2025 to a low of $5.1 million in Q3 2023.
- Historically, Short term Debt has averaged $9.7 million across 5 years, with a median of $8.9 million in 2026.
- The sharpest annual moves came in 2023 and 2025: Short term Debt slumped 58.85% in 2023, then jumped 256.12% in 2025.
- A 5-year view of Short term Debt shows it stood at $5.1 million in 2022, then grew by 3.95% to $5.3 million in 2023, then surged by 205.05% to $16.1 million in 2024, then tumbled by 35.17% to $10.5 million in 2025, then declined by 14.88% to $8.9 million in 2026.
- The last three Short term Debt figures came in at $8.9 million (Q1 2026), $10.5 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.90 Mn |
| Dec 31, 2025 | 10.46 Mn |
| Sep 30, 2025 | 18.24 Mn |
| Jun 30, 2025 | 18.23 Mn |
| Mar 31, 2025 | 16.79 Mn |
| Dec 31, 2024 | 16.13 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | 5.17 Mn |
| Dec 31, 2023 | 5.29 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Sep 30, 2022 | 10.38 Mn |
| Jun 30, 2022 | 11.31 Mn |
| Mar 31, 2022 | 12.61 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Dec 31, 2019 | 1.07 Mn |
| Dec 31, 2018 | 333,000.00 |